semaglutide gastric intestinal obstruction lawsuit in michigan and digestive blockage class action gastrointestinal Subocclusive ileus following off-label high-dose semaglutide use in: Endocrinology, Diabetes & Metabolism Case Reports Volume 2025 Issue 4 (2025) semaglutide gastric intestinal obstruction lawsuit

If additional glycemic control is needed after at least 4 weeks on the 0.5 mg dosage, the dosage may be increased to 1 mg once weekly

The price of single-dose vials of the weight loss drug Zepbound has been reduced on Eli Lilly's direct-to-consumer platform, LillyDirect, as the company also races to compete with its rival Novo Nordisk

The company has yet to announce any significant data from this study, which only began in May last year, with an estimated completion date of January 2026

It demonstrates an understanding of one's own body, needs, and limits

In patients with IgA deficiency, tTG-IgG or deamidated gliadin peptide (DGP) IgG antibodies should be used

However, it is highly unlikely that price negotiations on the drug will have concluded by January